CureSearch for Children's Cancer funds and supportstargeted and innovative children's cancer research with measurableresults, and is the authoritative source of information and resourcesfor all those affected by children's cancer.
Ending treatment for acute myeloid leukemia (AML) in children is, for many families and patients, a time of great joy. It is associated with "success" and with relief at no longer having to endure the many treatments and intense schedules that have developed. Many families also experience gratitude for having "made it through and survived."
At the same time, families face a new set of uncertainties. There are new requirements for medical monitoring and adjustments to a "new normal" life. And now that active treatment is ending, the hospital staff and the other families fighting cancer who have become essential support are no longer involved on a regular basis.
Different families react differently to this stage, focusing on the joy, uncertainty, sense of abandonment, or some mix of emotions. Even members of the same family can find themselves reacting differently to the end of treatment. Children, particularly younger children, rarely experience anything other than joy at being done with treatment, while parents often have concerns about how best to monitor and care for their child on their own.
One of the most common reactions to ending treatment, particularly for parents, is a fear that the cancer will come back. This happens because while in treatment, there was a protocol, medication was given and active therapy took place, as did frequent monitoring. Without the formal therapies and frequent testing, parents may feel they are not actively fighting the disease. It is important to remember that treatment has ended and monitoring has been reduced based on experience that it is now safe to do so.
The First Month off TreatmentTwo to Six Months off TreatmentSix to Twelve Months off TreatmentOne Year off Treatment and BeyondYoung Adults Transitioning to Adult-Focused CareLong-Term Follow-Up Care
The potential late effects following treatment for acute myeloid leukemia (AML) depend on the therapy received and the age at which it was received, as well as many other factors. Children treated with chemotherapy will be at less risk for some long-term effects than those treated with a stem cell transplant.
There are a couple of very important resources that you should be aware of as a survivor of children’s cancer. The Childhood Cancer Survivor Long-Term Follow-Up Guidelines, available at www.survivorshipguidelines.org, is a comprehensive set of healthcare screening guidelines designed for use by health care providers. In addition to the guidelines for healthcare providers, there is a series of Health Links that contain important information for patients regarding their long-term health. These Health Links cover a wide range of topics to assist patients in managing their ongoing health care. Your healthcare provider can review them with you.
About Acute Myeloid Leukemia Just Diagnosed with Acute Myeloid Leukemia In Treatment for Acute Myeloid Leukemia